1st Ethicon Physiomesh Lawsuit Will Head to Trial in December 2019, as Federal Court Revises Bellwether Schedule
The federal court overseeing hundreds of hernia mesh lawsuits involving Ethicon, Inc.’s Physiomesh Flexible Composite Mesh implants has revised its pretrial schedule, setting the stage for the first bellwether trial to begin in December 2019. First Physiomesh Bellwether Trial to … Continue reading
Monsanto Roundup Lawsuits Move Forward, as Federal MDL Preps for First Bellwether Trial
The federal court overseeing hundreds of cancer lawsuits involving Monsanto’s Roundup weed killer will convene its first bellwether trial in February 2019. More than 560 Roundup lawsuits are currently pending in the U.S. District Court, Northern District of California, where … Continue reading
Federal Panel Denies Plaintiffs’ Motion to Centralize Gadolinium MRI Contrast Dye Lawsuits
A judicial panel has denied a plaintiffs’ motion requesting centralization of all product liability lawsuits filed against the manufacturers of linear gadolinium-based MRI contrast dyes, or GBCAs, in a single U.S. District Court. Defendants Opposed Motion to Centralize Gadolinium Toxicity … Continue reading
Chinese Drug Maker Faces Multiple Valsartan Lawsuits Following Global Recalls
The Chinese pharmaceutical manufacturer responsible for dozens of valsartan recalls around the world is now facing legal headaches in the United States. According to FiercePharma.com, Zhejiang Huahai Pharmaceutical recently disclosed that it had been named a defendant in multiple valsartan … Continue reading
European Regulator Renews Birth Defect Warning for Dolutegravir-Containing HIV Drugs
European regulators have renewed warnings for dolutegravir, an HIV medication that has been linked to neural tube birth defects when taken in the earliest days of a pregnancy. Dolutegravir and Neural Tube Birth Defects Dolutegravir is currently sold in the United States … Continue reading
Antibiotic Lawsuit News: European Regulator Seeks to Restrict Levaquin, Other Fluoroquinolones
European regulators have recommended new restrictions for systemic fluoroquinolones, a class of antibiotics that has also drawn scrutiny – both legal and regulatory – in the United States. Systemic fluoroquinolones include oral, injectable, and inhaled versions of Levaquin, Cipro, and … Continue reading
Australian Cancer Group Wants Warning on Monsanto Roundup
Australia’s leading cancer group is calling for a new warning on all glyphosate-based herbicides sold in the Land Down Under, just weeks after the first Monsanto Roundup lawsuit trial in the United States concluded with a massive plaintiffs’ verdict. Australian Regulator … Continue reading
New Jersey Talcum Powder Jury Ready for Closing Arguments, as Mistral Declared in Latest California Asbestos Lawsuit
Closing arguments are expected to begin tomorrow in a closely-watched New Jersey trial involving the alleged link between Johnson & Johnson talcum powder products and mesothelioma, a deadly cancer tied to asbestos exposure. Meanwhile, a mistrial was declared in California’s most … Continue reading
Canada Bans Drug Imports from Chinese Firm at Center of Global Valsartan Recall
Health Canada has announced a ban on all imports from Zhejiang Huahai Pharmaceuticals, the Chinese manufacturer behind a massive worldwide recall for contaminated valsartan. The Canadian ban was announced on October 2nd, and followed a recent U.S. Food & Drug … Continue reading
Follow Us
